Interrater Agreement and Reliability of PERCIST and Visual Assessment When Using 18F-FDG-PET/CT for Response Monitoring of Metastatic Breast Cancer

por Sørensen, Jonas S., Vilstrup, Mie H., Holm, Jorun, Vogsen, Marianne, Bülow, Jakob L., Ljungstrøm, Lasse, Braad, Poul-Erik, Gerke, Oke, Hildebrandt, Malene G.
Publicado 2020

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST

por Vogsen, Marianne, Bülow, Jakob Lykke, Ljungstrøm, Lasse, Oltmann, Hjalte Rasmus, Alamdari, Tural Asgharzadeh, Naghavi-Behzad, Mohammad, Braad, Poul-Erik, Gerke, Oke, Hildebrandt, Malene Grubbe
Publicado 2021

Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer

por Naghavi-Behzad, Mohammad, Oltmann, Hjalte Rasmus, Alamdari, Tural Asgharzadeh, Bülow, Jakob Lykke, Ljungstrøm, Lasse, Braad, Poul-Erik, Asmussen, Jon Thor, Vogsen, Marianne, Kodahl, Annette Raskov, Gerke, Oke, Hildebrandt, Malene Grubbe
Publicado 2021